Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q2 2022 · 10-Q
Revenue$9.63M$9.63M−18.4% vs Q2 2021 Net Income-$4.66M-$4.66MN/M vs Q2 2021 EPS Diluted-$4.32-$4.32N/M vs Q2 2021 Gross Profit$6,442,322−21.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,202,062N/M Free Cash Flowderived-$5,344,827N/M Margins · derivedGross margin66.9%−2.2 pt vs Q2 2021
Operating margin-52.0%−16.7 pt vs Q2 2021
Net margin-48.4%+57.7 pt vs Q2 2021
ended Mar 31, 2022 · filed May 13, 2022 · 43 d after period end